Correction: [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. Open Access EJNMMI RESEARCH


Correction to: EJNMMI Research (2022) 12:43
https://doi.org/10.1186/s13550-022-00914-x Following publication of the original article [1], the authors were notified that 23 of the 91 imaging datasets had not been reconstructed properly. The corrected versions of the 23 mouse images include 11 APP/PS1 (5 mo.: 2 female and 2 male; 16 mo.: 2 female and 5 male) and 12 WT (5 mo. 2 female and 2 male; 16 mo.: 4 female and 4 male). Note that the correction of the imaging datasets make no difference to the conclusions reached in this study. In addition to these corrections, it came to the authors' attention that acknowledgement of a grant of number NS114656 had been omitted from the Funding declaration; the declaration has since been corrected. The original and the corrected versions of figures and statements in question may be seen below. The original article has been updated with the corrections.
The original published abstract for the related statement: "[ 18 F]ROStrace differences emerged mid-life, temporally and spatially correlating with increased Aβ burden (r 2 = 0.36; p = 0.0003), which was also greatest in the female brain (p < 0.001). " The corrected abstract for the related statement: "[ 18 F]ROStrace differences emerged mid-life, temporally and spatially correlating with increased Aβ burden (r 2 = 0.30; p = 0.0016), which was also greatest in the female brain (p < 0.001). " Fig. 2a and c: Hsieh et al. EJNMMI Research (2023) 13:16 The original published article for the related Results statement of Fig. 2a and c:
In order to understand the effect of aging on retention of [ 18 F]ROStrace in brain tissue, SUVR40-60 measurements were compared within female and male WT and APP/PS1 mice over time using a two-way ANOVA. The statistical comparisons show a decrease in several regions in male WT mice from 5 to 16 mo., but [ 18 F]ROStrace remained stable in most regions of the WT female brain over time (Additional file 1: The original published article for the related Results statement of Fig. 4a and e: "To evaluate the significance of this association, linear regression analysis was performed for amyloid burden vs. [ 18 F]ROStrace SUVR 40-60 in the cortex of APP/PS1 mice, which revealed a positive correlation between amyloid burden and [ 18 F]ROStrace (p = 0.0003, R 2 = 0.36; Fig. 4e). " The corrected article for the related Results statement of Fig. 4a and e: "To evaluate the significance of this association, linear regression analysis was performed for amyloid burden vs.

The original published article for the related Discussion statement:
"Interestingly, the only region with significantly different [ 18 F]ROStrace retention in WT females and males was the hypothalamus. " The corrected article for the related Discussion statement: "Interestingly, a significant difference in [ 18 F]ROStrace retention in WT females and males was observed in hypothalamus. " The original published article for the related Funding statement: This research was funded by the National Institutes of Health, National Institute of Aging, grant number AG055142.

The corrected article for the related Funding statement:
This research was funded by the National Institutes of Health, National Institute of Aging, grant number AG055142, and the National Institute of Neurological Disorders and Stroke grant number NS114656.